VTV THERAPEUTICS INC- CL A (VTVT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:VTVT • US9183852048

29.02 USD
-1.99 (-6.42%)
Last: Feb 6, 2026, 08:11 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to VTVT. VTVT was compared to 523 industry peers in the Biotechnology industry. While VTVT has a great health rating, there are worries on its profitability. VTVT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • VTVT had negative earnings in the past year.
  • VTVT had a negative operating cash flow in the past year.
  • In the past 5 years VTVT always reported negative net income.
  • In the past 5 years VTVT always reported negative operating cash flow.
VTVT Yearly Net Income VS EBIT VS OCF VS FCFVTVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • The Return On Assets of VTVT (-23.59%) is better than 73.14% of its industry peers.
  • VTVT's Return On Equity of -33.27% is fine compared to the rest of the industry. VTVT outperforms 74.10% of its industry peers.
Industry RankSector Rank
ROA -23.59%
ROE -33.27%
ROIC N/A
ROA(3y)-96.56%
ROA(5y)-79.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VTVT Yearly ROA, ROE, ROICVTVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

1.3 Margins

  • VTVT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VTVT Yearly Profit, Operating, Gross MarginsVTVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • VTVT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • VTVT has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for VTVT has been reduced compared to 5 years ago.
  • VTVT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VTVT Yearly Shares OutstandingVTVT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
VTVT Yearly Total Debt VS Total AssetsVTVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of -2.04, we must say that VTVT is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of VTVT (-2.04) is comparable to the rest of the industry.
  • There is no outstanding debt for VTVT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.04
ROIC/WACCN/A
WACC12.44%
VTVT Yearly LT Debt VS Equity VS FCFVTVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

2.3 Liquidity

  • A Current Ratio of 9.79 indicates that VTVT has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 9.79, VTVT belongs to the best of the industry, outperforming 80.19% of the companies in the same industry.
  • A Quick Ratio of 9.79 indicates that VTVT has no problem at all paying its short term obligations.
  • VTVT has a Quick ratio of 9.79. This is amongst the best in the industry. VTVT outperforms 80.76% of its industry peers.
Industry RankSector Rank
Current Ratio 9.79
Quick Ratio 9.79
VTVT Yearly Current Assets VS Current LiabilitesVTVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • VTVT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.84%, which is quite impressive.
  • VTVT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -98.30%.
  • The Revenue for VTVT have been decreasing by -18.10% on average. This is quite bad
EPS 1Y (TTM)24.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.17%
Revenue 1Y (TTM)-98.3%
Revenue growth 3Y-36.7%
Revenue growth 5Y-18.1%
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 4.83% on average over the next years.
  • The Revenue is expected to grow by 84.97% on average over the next years. This is a very strong growth
EPS Next Y-13.59%
EPS Next 2Y-8.67%
EPS Next 3Y-8.16%
EPS Next 5Y4.83%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y84.97%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VTVT Yearly Revenue VS EstimatesVTVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M
VTVT Yearly EPS VS EstimatesVTVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -50 -100

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VTVT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VTVT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VTVT Price Earnings VS Forward Price EarningsVTVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VTVT Per share dataVTVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • VTVT's earnings are expected to decrease with -8.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.67%
EPS Next 3Y-8.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • VTVT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VTV THERAPEUTICS INC- CL A

NASDAQ:VTVT (2/6/2026, 8:11:00 PM)

29.02

-1.99 (-6.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)03-18
Inst Owners29.16%
Inst Owner Change3.57%
Ins Owners0.42%
Ins Owner Change0%
Market Cap114.34M
Revenue(TTM)17.00K
Net Income(TTM)-23.47M
Analysts84.44
Price Target52.22 (79.94%)
Short Float %1.03%
Short Ratio1.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.69%
Min EPS beat(2)-9.33%
Max EPS beat(2)-8.04%
EPS beat(4)2
Avg EPS beat(4)7.01%
Min EPS beat(4)-9.33%
Max EPS beat(4)38.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)25.9%
PT rev (3m)44.23%
EPS NQ rev (1m)-2.96%
EPS NQ rev (3m)-6.67%
EPS NY rev (1m)-2.54%
EPS NY rev (3m)-13.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6725.81
P/FCF N/A
P/OCF N/A
P/B 1.62
P/tB 1.62
EV/EBITDA N/A
EPS(TTM)-3.32
EYN/A
EPS(NY)-4.4
Fwd EYN/A
FCF(TTM)-5.29
FCFYN/A
OCF(TTM)-5.29
OCFYN/A
SpS0
BVpS17.9
TBVpS17.9
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -23.59%
ROE -33.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-96.56%
ROA(5y)-79.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.79
Quick Ratio 9.79
Altman-Z -2.04
F-Score4
WACC12.44%
ROIC/WACCN/A
Cap/Depr(3y)7.41%
Cap/Depr(5y)4.44%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.17%
EPS Next Y-13.59%
EPS Next 2Y-8.67%
EPS Next 3Y-8.16%
EPS Next 5Y4.83%
Revenue 1Y (TTM)-98.3%
Revenue growth 3Y-36.7%
Revenue growth 5Y-18.1%
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y84.97%
EBIT growth 1Y-24.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.64%
OCF growth 3YN/A
OCF growth 5YN/A

VTV THERAPEUTICS INC- CL A / VTVT FAQ

What is the fundamental rating for VTVT stock?

ChartMill assigns a fundamental rating of 3 / 10 to VTVT.


What is the valuation status for VTVT stock?

ChartMill assigns a valuation rating of 0 / 10 to VTV THERAPEUTICS INC- CL A (VTVT). This can be considered as Overvalued.


Can you provide the profitability details for VTV THERAPEUTICS INC- CL A?

VTV THERAPEUTICS INC- CL A (VTVT) has a profitability rating of 1 / 10.


What is the earnings growth outlook for VTV THERAPEUTICS INC- CL A?

The Earnings per Share (EPS) of VTV THERAPEUTICS INC- CL A (VTVT) is expected to decline by -13.59% in the next year.